Raze｜長效抗菌光觸媒噴霧
擊退室內空氣5大隱形問題。
噴塗任何表面即可形成抗菌塗層，
享受全方位持久保護。
擊退室內空氣5大隱形問題。
噴塗任何表面即可形成抗菌塗層，
享受全方位持久保護。
Location: China, Hong Kong, Hong Kong Island
Employees: 11-50
Phone: +852 6907 8380
Founded date: 2018
Mentions in press and media 5
| Date | Title | Description |
| 07.12.2020 | #GiftGreenGiftKind: 25 Eco + Cruelty-Free Christmas Gifts From Local Brands | 15 2 17 Shares 12 Mins Read Forget 12 days of Christmas, we’re doing 25! Christmas is around the corner and now more than ever we need to vote with our dollar and #GiftGreenGiftKind from local, cruelty-free, plant-based and low waste busine... |
| 14.10.2014 | Raze Therapeutics targets newish metabolic pathway in cancer; raises $24M | The central idea behind Raze is to home in on targets in a set of biological pathways called “one carbon metabolism,” that help tumors grow. These pathways, Rhodes says, provide the tumors with substances needed to help them bulk up, cause ... |
| 14.10.2014 | Raze Therapeutics Launches with $24M Series A | CAMBRIDGE, MA, Biotechnology company leading the discovery and development of a new class of oncology therapeutics that target key metabolic pathways, has closed a $24 million Series A financing. >> Click here for more funding data... |
| 14.10.2014 | Raze Therapeutics Raises $24M in Series A Financing | Raze Therapeutics, a Cambridge, MA-based biotechnology company, closed a $24m Series A financing. Backers included Atlas Venture, MPM Capital Management, MS Ventures, Partners Innovation Fund, Astellas Venture Management, and Novartis. The ... |
| - | Raze Therapeutics targets newish metabolic pathway in cancer; raises $24M | Taking a fresh approach with a metabolic pathway that spurs cancer growth, spanking-new Cambridge cancer drug startup Raze Therapeutics has just raised a $24 million Series A. The company’s already got strong venture and big pharma backing ... |